AGER and cancer: While RAGE antibody-conjugated nanoparticles can bestow advantageous increase in bio-availability, cancer-specific cytotoxic efficacy and target specificity, AGE-conjugated nanoparticles can aid in targeting as well as imaging of RAGE over-expressing malignancies.